Furthermore, allopurinol, via inhibition of xanthine oxidases, could induce regression of LV mass in humans in a broad spectrum of diseases, including CKD, ischemic heart disease, and type 2 diabetes mellitus (21–23). Here, XDH is linked to chronic kidney disease.